Access Equity Research

News

Virtual & In-person Roadshows / Conferences

Channelchek Premium. Access more at no cost. 

The site "channelcheck" is opened on the phone

Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost. 

Access to Exclusive Content. FREE for Registered Users Only. 

Click “Log In” to agree to Channelchek.com <a href="#">Terms of Use</a> and acknowledge that Channelchek.com <a href="#">Privacy Policy</a> applies to you.

Welcome to the Channelchek Investor Community

Informed investors make more money. And it’s all about timing. Get it when it happens.

Inbox Intel from Channelchek.

<figure class="wp-block-image aligncenter size-full is-resized"><img src="https://dashboard.channelchek.com/wp-content/uploads/2022/03/ssp_logo.png" alt="" class="wp-image-7194" style="width:127px;height:auto"/></figure>



<a href="https://scripps.com/"></a><a href="http://www.channelchek.com/company/ssp">Research News and Market Data on SSP </a>



May 15, 2026 



By Rebecca McCarter



CINCINNATI –&nbsp;The E.W. Scripps Company (NASDAQ: SSP) has completed its local TV station swap with Gray Media across five mid-sized and small markets, expanding Scripps’ presence in the Mountain West.



Under the terms of the agreement, which was&nbsp;<a href="https://scripps.com/press-releases/gray-media-and-scripps-agree-to-swap-television-stations/">originally&nbsp;announced</a>&nbsp;in&nbsp;July&nbsp;2025:



<ul class="wp-block-list">
<li>Gray Media has acquired Scripps’ WSYM (Fox) in Lansing, Michigan, and KATC (ABC) in Lafayette, Louisiana.</li>



<li>Scripps has acquired Gray’s KKTV (CBS) in Colorado Springs, Colorado; KKCO (NBC) and KJCT-LP (ABC) in Grand Junction, Colorado; and KMVT (CBS) and KSVT-LD (Fox) in Twin Falls, Idaho.</li>
</ul>



The transaction expands Scripps’ presence in Colorado Springs and Twin Falls – markets where the company already operates trusted local stations – and establishes a new footprint in Grand Junction.



“Greater depth in these markets creates the economic durability to sustain our public service commitment: high-quality local news, emergency alerts, weather coverage and local sports that keep people informed, engaged and connected to their communities,” said Adam Symson, Scripps’ president and CEO. “We see scale and localism as complementary, and strategic transactions like this help ensure our stations remain strong, trusted voices for the communities that depend on us.”



The swap involves an even exchange of comparable assets with no cash consideration exchanged between the companies.



Investor contact:&nbsp;Jason Combs, The E.W. Scripps Company, (513) 977-3981,&nbsp;<a href="mailto:jason.combs@scripps.com">jason.combs@scripps.com</a> Media contact:&nbsp;Becca McCarter, The E.W. Scripps Company, (513) 410-2425,&nbsp;<a href="mailto:rebecca.mccarter@scripps.com">rebecca.mccarter@scripps.com</a>



About Scripps <a href="https://scripps.com/">The E.W. Scripps Company</a>&nbsp;(NASDAQ: SSP) is a diversified media company focused on creating connection. As one of the nation’s largest local TV broadcasters, Scripps serves communities with quality, objective local&nbsp;journalism and operates&nbsp;a portfolio of about 60 stations in 40 markets. Scripps reaches households across the U.S. with national news outlet Scripps News and popular entertainment brands ION, Bounce, Grit, ION Mystery, ION Plus and Laff. Scripps is the nation’s largest holder of broadcast spectrum. Scripps Sports&nbsp;serves professional and college sports leagues, conferences and teams with local market depth and national broadcast reach of up to 100% of TV households.&nbsp;Founded in 1878, Scripps is the steward of the Scripps National Spelling Bee, and its longtime motto is: “Give light and the people will find their own way.”

Research News and Market Data on SSP 



May 15, 2026 



By Rebecca McCarter



CINCINNATI –&nbsp;The E.W. Scripps Company (NASDAQ: SSP) has completed its local TV station swap with Gray Media across five mid-sized and small markets, expanding Scripps’ presence in the Mountain West.



Under the terms of the agreement, which was&nbsp;originally&nbsp;announced&nbsp;in&nbsp;July&nbsp;2025:




Gray Media has acquired Scripps’ WSYM (Fox) in Lansing, Michigan, and KATC (ABC) in Lafayette, Louisiana.



Scripps has acquired Gray’s KKTV (CBS) in Colorado Springs, Colorado; KKCO (NBC) and KJCT-LP (ABC) in Grand Junction, Colorado; and KMVT (CBS) and KSVT-LD (Fox) in Twin Falls, Idaho.




The transaction expands Scripps’ presence in Colorado Springs and Twin Falls – markets where the company already operates trusted local stations – and establishes a new footprint in Grand Junction.



“Greater depth in these markets creates the economic durability to sustain our public service commitment: high-quality local news, emergency alerts, weather coverage and local sports that keep people informed, engaged and connected to their communities,” said Adam Symson, Scripps’ president and CEO. “We see scale and localism as complementary, and strategic transactions like this help ensure our stations remain strong, trusted voices for the communities that depend on us.”



The swap involves an even exchange of comparable assets with no cash consideration exchanged between the companies.



Investor contact:&nbsp;Jason Combs, The E.W. Scripps Company, (513) 977-3981,&nbsp;jason.combs@scripps.comMedia contact:&nbsp;Becca McCarter, The E.W. Scripps Company, (513) 410-2425,&nbsp;rebecca.mccarter@scripps.com



About ScrippsThe E.W. Scripps Company&nbsp;(NASDAQ: SSP) is a diversified media company focused on creating connection. As one of the nation’s largest local TV broadcasters, Scripps serves communities with quality, objective local&nbsp;journalism and operates&nbsp;a portfolio of about 60 stations in 40 markets. Scripps reaches households across the U.S. with national news outlet Scripps News and popular entertainment brands ION, Bounce, Grit, ION Mystery, ION Plus and Laff. Scripps is the nation’s largest holder of broadcast spectrum. Scripps Sports&nbsp;serves professional and college sports leagues, conferences and teams with local market depth and national broadcast reach of up to 100% of TV households.&nbsp;Founded in 1878, Scripps is the steward of the Scripps National Spelling Bee, and its longtime motto is: “Give light and the people will find their own way.”

Release - Scripps completes station swap with Gray Media

E.W. Scripps

<figure class="wp-block-image aligncenter is-resized"><img src="https://www.starequity.com/sites/g/files/knoqqb103841/themes/site/nir_pid1851/dist/img/star-equity-holdings-logo.png" alt="Star Equity Holdings" style="width:194px;height:auto"/></figure>



<a href="http://www.channelchek.com/company/strr">Research News and Market Data on STRR</a>



May 15, 2026



<a href="https://www.starequity.com/node/28191/pdf" target="_blank" rel="noreferrer noopener">Download PDF</a>



OLD GREENWICH, Conn.,&nbsp;May 15, 2026&nbsp;(GLOBE NEWSWIRE) --&nbsp;Star Equity Holdings, Inc.&nbsp;(Nasdaq: STRR and STRRP) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company’s 10% Series A Cumulative Perpetual Preferred Stock of&nbsp;$0.25&nbsp;per share. The record date for this dividend is&nbsp;June 1, 2026, and the payment date is&nbsp;June 10, 2026.



About&nbsp;Star Equity Holdings, Inc. Star Equity Holdings, Inc.&nbsp;is a diversified holding company that seeks to build long-term shareholder value by acquiring, managing, and growing businesses with strong fundamentals and market opportunities. Its current structure comprises four divisions: Building Solutions, Business Services, Energy Services, and Investments. For more information visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=fxrq69tTyxPXgb8UFVj7em5JEnTAOTQrFkvGk_zdEFMh8G3HtgqPYwtHqF4PelFB-FxZGB7ZBoj2G2zbsu42tPdi5X0U7CZlwWIep8wdxFs=" rel="noreferrer noopener" target="_blank">www.starequity.com</a>.



On&nbsp;August 22, 2025, the Company completed its previously announced acquisition of&nbsp;Star Operating Companies, Inc.&nbsp;(“Star Operating”, formerly known as&nbsp;Star Equity Holdings, Inc.), pursuant to the Agreement and Plan of Merger, dated as of&nbsp;May 21, 2025&nbsp;(the “Merger Agreement”), by and among the Company,&nbsp;Star Operating and HSON Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, on&nbsp;August 22, 2025, at the effective time of the merger pursuant to the Merger Agreement (the “Merger”), Merger Sub merged with and into Star Operating, with Star Operating continuing as the surviving corporation of the Merger as a wholly owned subsidiary of the Company. Effective&nbsp;September 5, 2025, the Company changed (i) its name to&nbsp;Star Equity Holdings, Inc.&nbsp;and (ii) its trading symbols on Nasdaq to STRR and STRRP.



Building Solutions The&nbsp;Building Solutions&nbsp;division operates in three specialties: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber (glulam) column, beam, and truss manufacturing.



Business Services The Business Services division provides flexible and scalable recruitment solutions to a global clientele, servicing organizations at all levels, from entry-level positions to the C-suite. The division focuses on mid-market and enterprise organizations worldwide, partnering consultatively with talent acquisition, HR, and procurement leaders to build diverse, high-impact teams and drive business success.



Energy Services The Energy Services division engages in the rental, sale, and repair of downhole tools used in the oil and gas, geothermal, mining, and water-well industries.



Investments The Investments division manages and finances the Company’s real estate assets as well as its investment positions in private and public companies.



For more information contact: The Equity Group Lena Cati Senior Vice President 212-836-9611 <a href="https://www.globenewswire.com/Tracker?data=E7lR2ybC1-B8UK6PHPue3k8vUO4szneNfdXCcH8QBC8aZkVvbjNT34OZFT-HtrDwfa8sH1OPDlN7zFp840sZ3o1-8q8rso73eamlx_39sKbUrGlQWl9puNDMKVZ4jZ4D" rel="noreferrer noopener" target="_blank">lcati@theequitygroup.com</a>



Forward-Looking Statements This press release contains statements that the Company believes to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company’s future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “predict,” “believe,” and similar words, expressions, and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties, and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described in the forward-looking statements. Such factors, risks, uncertainties, and assumptions include, but are not limited to, (1) global economic fluctuations, (2) changes in the cost and availability of commodities, materials, and equipment, (3) risks related to providing uninterrupted service to clients, (4) the ability of clients to terminate their relationship with the Company at any time, (5) risks associated with real estate ownership, (6) the Company’s ability to successfully achieve its strategic initiatives, (7) risks related to fluctuations in the Company’s operating results from quarter to quarter, (8) risks related to potential acquisitions or dispositions of businesses by the Company, (9) our profitability and growth being tied to the success of our operating businesses, (10) risks associated with our financial investments in other businesses, (11) our ability to improve existing products and services and develop, introduce, and market new products and services successfully, (12) the loss of or material reduction in our business with any of the Company’s largest customers, (13) competition in the Company’s markets, (14) risks related to potential decreases in demand for products, (15) our ability to maintain costs at an acceptable level, (16) the negative cash flows and operating losses that may recur in the future, (17) risks related to international operations, including foreign currency fluctuations, political events, trade wars, natural disasters or health crises, including the&nbsp;Russia-Ukraine&nbsp;war, and potential conflict in the&nbsp;Middle East, (18) risks relating to how future credit facilities may affect or restrict our operating flexibility, (19) our ability to generate or borrow sufficient cash to make payments on our indebtedness, (20) risks related to indebtedness, (21) risks associated with the Company’s investment strategy, (22) the Company’s dependence on key management personnel, (23) the Company’s ability to attract and retain highly skilled professionals, management, and advisors, (24) the Company’s ability to collect accounts receivable, (25) the Company’s exposure to legal proceedings, investigations and disputes, and limits on related insurance coverage, (26) the Company’s ability to utilize net operating loss carryforwards, (27) the potential for goodwill impairment, (28) volatility of the Company’s stock price, (29) risks related to our historically low trading volume, (30) risks related to securities or industry analysts, (31) the Company’s ability to declare dividends, (32) risks associated with failure to pay dividends on our Series A Preferred Stock, (33) our history of annual net losses, (34) risks related to our international operations, (35) risks related to compliance with federal and state laws, regulations, and other rules, (36) our exposure to employment-related claims, legal liability, and costs from clients, employees, and regulatory authorities, (37) risks related to the imposition of licensing or tax requirements or new regulations, (38) the effect of Anti-takeover provisions in our organizational documents, (39) the effect of the protective amendment contained in our Restated Certificate of Incorporation, (40) the impact of our stockholder rights plan, or “poison pill,” on stockholder decision making, (41) risks related to our scaled disclosure requirements as a smaller reporting company, (42) the Company’s heavy reliance on information systems and the impact of potentially losing or failing to develop technology, (43) the adverse impacts of cybersecurity threats and attacks, and (44) risks related to the use of new and evolving technologies, and (45) those risks set forth in “Risk Factors in the Company’s Annual Report on Form 10-K for the year ended&nbsp;December 31, 2025.”&nbsp;&nbsp;The foregoing list should not be construed to be exhaustive. Actual results could differ materially from the forward-looking statements contained in this press release. In view of these uncertainties, you should not place undue reliance on any forward-looking statements, which are based on our current expectations. These forward-looking statements speak only as of the date of this press release. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.<img alt="" src="https://www.globenewswire.com/newsroom/ti?nf=OTcyMDk4NiM3NjA1MjU0IzIwMTg5OTQ="> <img alt="" src="https://ml.globenewswire.com/media/Y2YxN2YwNDUtZjA0NC00YzlkLWIwYWQtNmUwMmE5ZTk5Y2JhLTEwMzA1NjctMjAyNi0wNS0xNS1lbg==/tiny/Star-Equity-Holdings-Inc-.png">



<figure class="wp-block-image"><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/3599cc5f-a13a-444e-a506-7126733e4a9a"><img src="https://ml.globenewswire.com/media/3599cc5f-a13a-444e-a506-7126733e4a9a/small/strr-png.png" alt="Primary Logo"/></a></figure>



Source: Star Equity Holdings, Inc.

Research News and Market Data on STRR



May 15, 2026



Download PDF



OLD GREENWICH, Conn.,&nbsp;May 15, 2026&nbsp;(GLOBE NEWSWIRE) &#8212;&nbsp;Star Equity Holdings, Inc.&nbsp;(Nasdaq: STRR and STRRP) (&#8220;Star&#8221; or the &#8220;Company&#8221;), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company’s 10% Series A Cumulative Perpetual Preferred Stock of&nbsp;$0.25&nbsp;per share. The record date for this dividend is&nbsp;June 1, 2026, and the payment date is&nbsp;June 10, 2026.



About&nbsp;Star Equity Holdings, Inc.Star Equity Holdings, Inc.&nbsp;is a diversified holding company that seeks to build long-term shareholder value by acquiring, managing, and growing businesses with strong fundamentals and market opportunities. Its current structure comprises four divisions: Building Solutions, Business Services, Energy Services, and Investments. For more information visit&nbsp;www.starequity.com.



On&nbsp;August 22, 2025, the Company completed its previously announced acquisition of&nbsp;Star Operating Companies, Inc.&nbsp;(“Star Operating”, formerly known as&nbsp;Star Equity Holdings, Inc.), pursuant to the Agreement and Plan of Merger, dated as of&nbsp;May 21, 2025&nbsp;(the “Merger Agreement”), by and among the Company,&nbsp;Star Operating and HSON Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, on&nbsp;August 22, 2025, at the effective time of the merger pursuant to the Merger Agreement (the “Merger”), Merger Sub merged with and into Star Operating, with Star Operating continuing as the surviving corporation of the Merger as a wholly owned subsidiary of the Company. Effective&nbsp;September 5, 2025, the Company changed (i) its name to&nbsp;Star Equity Holdings, Inc.&nbsp;and (ii) its trading symbols on Nasdaq to STRR and STRRP.



Building SolutionsThe&nbsp;Building Solutions&nbsp;division operates in three specialties: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber (glulam) column, beam, and truss manufacturing.



Business ServicesThe Business Services division provides flexible and scalable recruitment solutions to a global clientele, servicing organizations at all levels, from entry-level positions to the C-suite. The division focuses on mid-market and enterprise organizations worldwide, partnering consultatively with talent acquisition, HR, and procurement leaders to build diverse, high-impact teams and drive business success.



Energy ServicesThe Energy Services division engages in the rental, sale, and repair of downhole tools used in the oil and gas, geothermal, mining, and water-well industries.



InvestmentsThe Investments division manages and finances the Company’s real estate assets as well as its investment positions in private and public companies.



For more information contact:The Equity GroupLena CatiSenior Vice President212-836-9611lcati@theequitygroup.com



Forward-Looking StatementsThis press release contains statements that the Company believes to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company’s future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “predict,” “believe,” and similar words, expressions, and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties, and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described in the forward-looking statements. Such factors, risks, uncertainties, and assumptions include, but are not limited to, (1) global economic fluctuations, (2) changes in the cost and availability of commodities, materials, and equipment, (3) risks related to providing uninterrupted service to clients, (4) the ability of clients to terminate their relationship with the Company at any time, (5) risks associated with real estate ownership, (6) the Company’s ability to successfully achieve its strategic initiatives, (7) risks related to fluctuations in the Company’s operating results from quarter to quarter, (8) risks related to potential acquisitions or dispositions of businesses by the Company, (9) our profitability and growth being tied to the success of our operating businesses, (10) risks associated with our financial investments in other businesses, (11) our ability to improve existing products and services and develop, introduce, and market new products and services successfully, (12) the loss of or material reduction in our business with any of the Company’s largest customers, (13) competition in the Company’s markets, (14) risks related to potential decreases in demand for products, (15) our ability to maintain costs at an acceptable level, (16) the negative cash flows and operating losses that may recur in the future, (17) risks related to international operations, including foreign currency fluctuations, political events, trade wars, natural disasters or health crises, including the&nbsp;Russia-Ukraine&nbsp;war, and potential conflict in the&nbsp;Middle East, (18) risks relating to how future credit facilities may affect or restrict our operating flexibility, (19) our ability to generate or borrow sufficient cash to make payments on our indebtedness, (20) risks related to indebtedness, (21) risks associated with the Company’s investment strategy, (22) the Company’s dependence on key management personnel, (23) the Company’s ability to attract and retain highly skilled professionals, management, and advisors, (24) the Company’s ability to collect accounts receivable, (25) the Company’s exposure to legal proceedings, investigations and disputes, and limits on related insurance coverage, (26) the Company’s ability to utilize net operating loss carryforwards, (27) the potential for goodwill impairment, (28) volatility of the Company’s stock price, (29) risks related to our historically low trading volume, (30) risks related to securities or industry analysts, (31) the Company’s ability to declare dividends, (32) risks associated with failure to pay dividends on our Series A Preferred Stock, (33) our history of annual net losses, (34) risks related to our international operations, (35) risks related to compliance with federal and state laws, regulations, and other rules, (36) our exposure to employment-related claims, legal liability, and costs from clients, employees, and regulatory authorities, (37) risks related to the imposition of licensing or tax requirements or new regulations, (38) the effect of Anti-takeover provisions in our organizational documents, (39) the effect of the protective amendment contained in our Restated Certificate of Incorporation, (40) the impact of our stockholder rights plan, or “poison pill,” on stockholder decision making, (41) risks related to our scaled disclosure requirements as a smaller reporting company, (42) the Company’s heavy reliance on information systems and the impact of potentially losing or failing to develop technology, (43) the adverse impacts of cybersecurity threats and attacks, and (44) risks related to the use of new and evolving technologies, and (45) those risks set forth in “Risk Factors in the Company’s Annual Report on Form 10-K for the year ended&nbsp;December 31, 2025.”&nbsp;&nbsp;The foregoing list should not be construed to be exhaustive. Actual results could differ materially from the forward-looking statements contained in this press release. In view of these uncertainties, you should not place undue reliance on any forward-looking statements, which are based on our current expectations. These forward-looking statements speak only as of the date of this press release. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.







Source: Star Equity Holdings, Inc.

Release - Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

Diversified Industries

Star Equity Holdings

STRR

Research News and Market Data on COCP 



May 15, 2026



&nbsp;Download as PDF



&nbsp;PDF



Release



&nbsp;PDF&nbsp;&nbsp;HTML



10-QFiling



&nbsp;ZIP&nbsp;&nbsp;XLS&nbsp;&nbsp;HTML



XBRL




Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment cohorts



Highlighted CDI-988’s mechanism of action and clinical advancement at ICAR 2026



Granted FDA Fast Track designation for CDI-988, enabling the potential for an accelerated development pathway



Received initial $225,000 of SBIR NIH grant for influenza A and B antiviral lead generation




BOTHELL, Wash., May 15, 2026 (GLOBE NEWSWIRE) &#8212;&nbsp;Cocrystal Pharma, Inc.&nbsp;(Nasdaq: COCP) (“Cocrystal” or the “Company”) provides updates on its antiviral product pipeline and business activities and reports financial results for the three months ended March 31, 2026.



“Advancing&nbsp;CDI-988&nbsp;into a Phase 1b human challenge study is a pivotal milestone for the Company and a meaningful step in our clinical strategy. The study’s innovative design allows us to efficiently evaluate&nbsp;CDI-988&nbsp;as a preventive and as a treatment for norovirus infection,” said Sam Lee, Ph.D., President and co-CEO of Cocrystal Pharma. “We were pleased to receive FDA Fast Track designation for CDI-988, which speaks to the significant unmet need in norovirus and provides a potential pathway to accelerate our work to address a widespread and underserved public health burden.”



The ongoing Phase 1b randomized, double‑blind, placebo‑controlled challenge study (NCT07198139) is being conducted at Emory University School of Medicine in collaboration with the University of North Carolina. The study is designed to enroll up to 40 healthy adults, aged 18 to 49, in staged cohorts. The stage 1 infectivity cohort, now fully enrolled, will be followed by prevention and treatment cohorts in which&nbsp;CDI‑988&nbsp;is administered at 1,200 mg twice daily for five days. The subjects in the prevention and treatment cohort have been enrolled. The primary efficacy endpoint is reduction in the incidence of clinical symptoms, with secondary endpoints including reduction in viral shedding, disease severity, safety and pharmacokinetics.



“We recently received the initial payment under our SBIR Phase I award, bringing in non-dilutive funding to advance our influenza A and B program toward clinical development,” said James Martin, CFO and co-CEO of Cocrystal Pharma. “The successful completion of this first phase could position us to compete for a larger Phase II award to support continued development. This award demonstrates our ongoing commitment to pursuing government and military funding to build and advance our antiviral pipeline.”



Antiviral Product Pipeline Overview



We leverage our proprietary structure-based drug discovery platform technology to develop next-generation, broad-spectrum antivirals that effectively block viral replication. Unlike other drug discovery approaches, our technology identifies compounds that bind to highly conserved regions of viral drug targets, including proteases and replication enzymes. By specifically targeting these essential viral functions, our drug candidates maintain efficacy as viruses mutate, while simultaneously minimizing off-target interactions that typically lead to adverse side effects. This dual advantage represents a significant breakthrough in antiviral drug development. In addition, our innovative methodology fundamentally transforms the conventional drug discovery paradigm by eliminating the inefficient, resource-intensive cycles of high-throughput compound screening and prolonged hit-to-lead optimization. The result is faster identification of promising candidates with superior resistance profiles and safety characteristics.



Norovirus ProgramNorovirus is a common, highly contagious virus that afflicts people of all ages and causes symptoms of acute gastroenteritis including nausea, vomiting, stomach pain and diarrhea, as well as fatigue, fever and dehydration. There are currently no effective treatments or vaccines for norovirus, and the ability to curtail outbreaks is inadequate.



With 685 million global cases annually and a $60 billion worldwide economic impact, norovirus represents one of healthcare&#8217;s most pressing unmet needs.&nbsp;In the U.S., noroviruses are responsible for an estimated 21 million infections annually, including an estimated 109,000 hospitalizations, 465,000 emergency department visits and 900 deaths. The annual burden of norovirus to the U.S. is estimated at&nbsp;$10.6 billion. In the developing world, each year noroviruses are responsible for&nbsp;up to 1.1 million hospitalizations and 218,000 pediatric deaths.



Oral protease inhibitor&nbsp;CDI-988&nbsp;for the treatment of noroviruses and coronaviruses:&nbsp;Our first oral direct-acting antiviral&nbsp;CDI-988&nbsp;targets the highly conserved region of the 3CL protease and is designed as a potential therapeutic for noroviruses and coronaviruses.&nbsp;CDI-988&nbsp;has shown&nbsp;in vitro&nbsp;activity against multiple norovirus strains.




In April 2025 we announced that CDI-988 showed superior broad-spectrum antiviral activity against the norovirus GII.17 strain, the most prevalent strain in the U.S. and Europe in 2024-2025.



In August 2025 we presented favorable Phase 1 safety and tolerability data from all CDI-988 doses, including a high-dose 1,200 mg cohort, at the 2025 Military Health System Research Symposium (MHSRS).



In September 2025 we discussed CDI-988’s scientific foundation and clinical progress in an oral presentation at the 9th International Calicivirus Conference, the leading calicivirus scientific meeting.



In September 2025 we received a Study May Proceed Letter from the FDA to conduct a Phase 1b challenge study in the U.S. evaluating CDI-988 as a norovirus preventive and treatment.



In March 2026 we enrolled the first subjects in our Phase 1b challenge study, which is being conducted at Emory University School of Medicine.



In April 2026 we announced full enrollment in the first cohort of the Phase 1b study, which is evaluating the infectivity rate of the GII.2 challenge inoculum, at the International Conference on Antiviral Research 2026 (ICAR 2026).



The subjects have been enrolled in the prevention and treatment cohort.




Influenza ProgramsInfluenza is a major global health threat that may become more challenging to treat due to the emergence of highly pathogenic avian influenza viruses and resistance to approved influenza antivirals. Currently approved antiviral treatments for influenza are effective but are burdened with significant viral resistance.



Each year approximately 1 billion cases of seasonal influenza, 3-5 million severe illnesses and up to 650,000 deaths&nbsp;are reported worldwide.&nbsp;About 8% of the U.S. population gets sick from flu each season. In addition to the health risk,&nbsp;influenza is responsible for an estimated $10.4 billion in direct medical costs in the U.S. each year.



CC-42344&nbsp;is our novel PB2 inhibitor that showed excellent&nbsp;in vitro&nbsp;activity against pandemic and seasonal influenza A strains, as well as against strains that are resistant to Tamiflu®&nbsp;and Xofluza®.




Oral CC-42344 as a treatment for pandemic and seasonal influenza A

In December 2022 we reported favorable Phase 1 safety and tolerability results.



In December 2023 we began a randomized, double-blind, placebo-controlled Phase 2a human challenge study to evaluate the safety, tolerability, and viral and clinical measurements of CC-42344 in influenza A-infected subjects in the United Kingdom, following authorization from the UK Medicines and Healthcare Products Regulatory Agency.



In May 2025 we reported that CC-42344 was shown to be active against the highly pathogenic 2024 Texas H5N1 avian influenza strain.



In November 2025 an initial Phase 2a study was completed, with CC-42344 showing a favorable safety and tolerability profile with no serious adverse events and no drug-related discontinuations by study participants. Efficacy analyses were not reported due to issues with trial conduct.



We plan to continue development of oral CC-42344 as a treatment for pandemic and seasonal influenza A with an additional Phase 2a study.







Inhaled CC-42344 as prophylaxis and treatment for pandemic and seasonal influenza A

Our preclinical testing showed superior pulmonary pharmacology with CC-42344, including high exposure to drug and a long half-life.



We have developed a dry powder inhalation formulation of CC-42344 and have completed toxicology studies.





Influenza A/B program

In October 2025 we were awarded an approximate $500,000 Small Business Innovation Research (SBIR) Phase I grant from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases to support the development of a novel, broad-spectrum lead candidate targeting the influenza A/B polymerase complex.



In the first quarter of 2026 we received $225,000 under the SBIR award.






SARS-CoV-2 and Other Coronavirus Program



By targeting viral replication enzymes and proteases, we believe it is possible to develop effective treatments for all diseases caused by coronaviruses including SARS-CoV-2 and its variants, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome.&nbsp;CDI-988&nbsp;showed potent&nbsp;in vitro&nbsp;pan-viral activity against common human coronaviruses, rhinoviruses and respiratory enteroviruses, as well as against noroviruses.&nbsp;By the end of 2031, the global COVID-19 therapeutics market is estimated to exceed $16 billion annually.



Oral protease inhibitor&nbsp;CDI-988&nbsp;for the treatment of coronaviruses and noroviruses: CDI-988&nbsp;exhibited superior&nbsp;in vitro&nbsp;potency against SARS-CoV-2 and demonstrated a favorable safety profile and pharmacokinetic properties.




In August 2025 we presented favorable safety and tolerability Phase 1 data from all CDI-988 doses, including a high-dose 1,200 mg cohort, at the MHSRS.



We are currently pursuing further development of CDI-988 as a preventive and treatment for norovirus infection and remain optimistic about its viability as a treatment for coronaviruses.




First Quarter Financial Results



Revenue for the first quarter of 2026 was $225,000, representing payments from an NIH SBIR award for an influenza A/B Inhibitor program. The Company reported no revenue for the first quarter of 2025.



Research and development expenses for the first quarters of 2026 and 2025 were $1.4 million. General and administrative expenses for the first quarter of 2026 were $1.2 million compared with $1.0 million for the first quarter of 2025, with the increase primarily due to an increase in legal and consultant costs, partially offset by a decrease in salaries and wages.



Net loss for the first quarter of 2026 was $2.3 million, or $0.17 per share on 13.8 million common shares outstanding, compared with a net loss for the first quarter of 2025 of $2.3 million, or $0.23 per share on 10.2 common shares outstanding.&nbsp;&nbsp;



Cocrystal reported unrestricted cash as of March 31, 2026, of $4.7 million compared with $7.7 million as of December 31, 2025. Net cash used in operating activities was $2.3 million for the three months ended March 31, 2026, compared with $2.9 million for the same period in 2025. The Company had working capital of $3.7 million as of March 31, 2026.



About Cocrystal Pharma, Inc.



Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2) and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create viable antiviral drugs. For further information about Cocrystal, please visit&nbsp;www.cocrystalpharma.com.



Cautionary Note Regarding Forward-Looking Statements



This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the ongoing Phase 1b norovirus trial, our future potential for government grants, and the further development of our oral CC-42344 product candidate. The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;could,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;is likely,&#8221; &#8220;will,&#8221; &#8220;expect&#8221; and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events. Some or all of the events anticipated by these forward-looking statements may not occur. Important factors that could cause actual results to differ from those in the forward-looking statements include, but are not limited to, the risks and uncertainties arising from inflation, affordability, a deteriorating labor market, the possibility of a recession, increases or other developments with respect to interest rates, uncertainty surrounding the impacts arising from imposed and threatened tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in Ukraine and with Iran on our Company, our collaboration partners, and on the U.S. and global economies, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business interruptions including any adverse impacts on our ability to obtain raw materials and test animals as well as similar problems with our vendors and our current and any future CROs and CMOs, the progress and results of the studies for CDI-988 and CC-42344 including issues with the initial Phase 2a study for CC-42344 which will prolong the development timeline of such product candidate, the ability of our CROs to recruit volunteers for, and to proceed with, clinical studies, our and our collaboration partners’ technology and software performing as expected, financial difficulties experienced by certain partners, the results of future preclinical and clinical trials, general risks arising from clinical trials, receipt of regulatory approvals, regulatory changes and potential litigation challenging initiatives and actions taken by the Trump Administration which could, among other things, result in delays in regulatory approvals or limit access to federal funding for our programs, development of effective treatments and/or vaccines by competitors, including as part of the programs financed by the U.S. government, potential mutations in a virus we are targeting which may result in variants that are resistant to a product candidate we develop, and our liquidity. Further information on our risk factors is contained in our filings with the SEC, including the “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.



Investor Contact:Alliance Advisors IRBruce Vossbvoss@allianceadvisors.com310-691-7104



View full release here.

Release - Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

COCP

Cocrystal Pharma

<figure class="wp-block-image aligncenter is-resized"><img src="https://s29.q4cdn.com/176696086/files/design/MP_SH_Logo_RGB_Red-removebg-preview.png" alt="Sky Harbour Logo" style="aspect-ratio:5.3910950661853185;width:191px;height:auto"/></figure>



<a href="http://www.channelchek.com/company/skyh">Research News and Market Data on SKYH</a>



05/14/2026



Introduces Guidance for Year End 2026



WEST HARRISON, N.Y.--(BUSINESS WIRE)-- Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home Base Operator (HBO) campuses for business aircraft, announced the release of its unaudited financial results for the three months ended March 31, 2026 on Form 10-Q. The Company also announced the filing of its unaudited financial results for the three months ended March 31, 2026 for Sky Harbour Capital LLC (Obligated Group) with MSRB/EMMA. Please see the following links to access the filings:



SEC 10-Q:



<a href="https://www.sec.gov/Archives/edgar/data/1823587/000143774926017035/ysac20260331_10q.htm">https://www.sec.gov/Archives/edgar/data/1823587/000143774926017035/ysac20260331_10q.htm</a>



MSRB/EMMA:



<a href="https://emma.msrb.org/P11953837-P11491752-P11944016.pdf">https://emma.msrb.org/P11953837-P11491752-P11944016.pdf</a>



Financial Highlights on a Consolidated Basis include:



<ul class="wp-block-list">
<li>Constructed assets and construction in progress reached over $350 million at quarter-end, an increase of $75 million year-over-year.</li>



<li>Q1 2026 consolidated revenues increased 56% as compared to Q1 2025 and 8.3% as compared sequentially to the prior quarter.</li>



<li>Net cash used in operating activities was approximately $3.9 million for the quarter, compared to approximately $5.1 million used in Q1 2025.</li>



<li>Strong liquidity and capital resources at quarter end, with consolidated cash and US Treasuries totaling $187.6 million and access to $180.6 million of the committed JP Morgan drawdown construction bank facility (“JPM Facility”).</li>



<li>Refer to our 10-Q for presentation of GAAP net income and adjusted EBITDA (Non-GAAP) results.</li>
</ul>



Financial Highlights at Sky Harbour Capital LLC (“Obligated Group”) include:



<ul class="wp-block-list">
<li>Q1 2026 Obligated Group revenues increased 76.2% as compared to Q1 2025 and 15.1% as compared sequentially to the prior quarter.</li>



<li>Net cash provided by operating activities reached approximately $2.9 million in Q1 2026, an increase from the $1.0 million cash provided by operating activities in Q1 2025.</li>



<li>Cash and US Treasuries at the Obligated Group totaled $17.9 million as of March 31st, 2026 apart from access to the proceeds of the Series 2026 Bonds for construction completion of Phase 2 at Addison Airport (“ADS”).</li>



<li>Debt Service Coverage Tests, calculated as per the Bond Indenture for the period ending March 31st, 2026 and the next twelve months budget are in compliance with applicable covenant ratios.</li>
</ul>



Update on Leasing Activities



<ul class="wp-block-list">
<li>Stabilized campuses: The Company continues to enjoy higher-than-forecast revenue per square foot at its stabilized campuses, with economic occupancy reaching 103% for campuses open for more than 6 months. Revenue per square foot continues to grow as legacy hangar leases turn over.</li>



<li>Miami–Opa Locka Executive Airport (“OPF”) Phase 2 opened May 11 with 68% occupancy as of May 13th, at average contracted revenue per square foot higher than the highest revenue tenant at OPF Phase 1.</li>



<li>As of May 13th, Dallas Addison Airport (“ADS”) Phase 1, Phoenix Deer Valley Airport (“DVT”) Phase 1 and Denver Centennial Airport (“APA”) have achieved 91%, 76% and 44% occupancy respectively.</li>
</ul>



Update on Construction and Development Activities



<ul class="wp-block-list">
<li>Obligated Group 1 Construction
<ul class="wp-block-list">
<li>OPF Phase 2 received Temporary Certificates of Occupancy on May 11th and is now operational.</li>



<li>ADS Phase 2 is on schedule, expected to open prior to the end of the year. Please see the following link for the latest Obligated Group monthly construction report: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Femma.msrb.org%2FP22034299-P21548857-P22007097.pdf&amp;esheet=54535253&amp;newsitemid=20260514438745&amp;lan=en-US&amp;anchor=https%3A%2F%2Femma.msrb.org%2FP22034299-P21548857-P22007097.pdf&amp;index=3&amp;md5=e41a51b6245fd92dce7cd3b2f620e54a">https://emma.msrb.org/P22034299-P21548857-P22007097.pdf</a></li>
</ul>
</li>



<li>Portfolio 2 Construction
<ul class="wp-block-list">
<li>Bradley International Airport (“BDL”) in Hartford, CT is on schedule, expected to be completed by November 2026.</li>



<li>Salt Lake City International Airport (“SLC”) is on schedule, expected to be completed in Q1 2027.</li>



<li>Hudson Valley Regional Airport (“POU”), in Poughkeepsie, NY is on schedule, expected to be completed by Q3 2027.</li>



<li>Orlando Executive Airport (“ORL”) is on schedule, expected to be completed by Q3 2027</li>



<li>BDL, SLC and POU are part of our second portfolio of airport projects (“Portfolio II”), financed through the JPM Facility and the Series 2026 Bonds. Their construction progress can be monitored through a monthly construction report filed with MSRB/EMMA: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Femma.msrb.org%2FP22035088-P21549466-P22007738.pdf&amp;esheet=54535253&amp;newsitemid=20260514438745&amp;lan=en-US&amp;anchor=https%3A%2F%2Femma.msrb.org%2FP22035088-P21549466-P22007738.pdf&amp;index=4&amp;md5=26982e41d2400ac86a225c1ab0f01d15">https://emma.msrb.org/P22035088-P21549466-P22007738.pdf</a></li>
</ul>
</li>



<li>Portfolio 2 Development
<ul class="wp-block-list">
<li>Washington Dulles International Airport (IAD), Trenton-Mercer Airport (TTN) in New Jersey, and Chicago Executive Airport (PWK) are all scheduled to begin construction by Q4 2026.</li>
</ul>
</li>
</ul>



Update on Airport Operations



<ul class="wp-block-list">
<li>As of Q1 2026, the Company is operating 1.03 million square feet of hangar and associated office and support space, with approximately 2 million square feet of aviation ramp and vehicle parking.</li>



<li>Surveys of current Residents, which include the nation’s premier business aviation flight departments, indicate that Sky Harbour’s HBO service offering has become a recognized and clearly differentiated offering in business aviation, and is emphatically the solution of choice for top business aviation operators.</li>



<li>The Company continues to invest in constant improvement in service and operations, through selective recruiting, rigorous training and talent development, detailed and thoughtful operating procedures, and constant innovation in collaboration with Sky Harbour Residents.</li>
</ul>



Update on Capital Formation



<ul class="wp-block-list">
<li>As previously reported, Sky Harbour Capital III LLC, a wholly owned, indirect subsidiary of the Company, issued $150 million of subordinated bonds through the Public Finance Authority of Wisconsin municipal conduit on February 12th. Proceeds are earmarked to completing projects at ADS 2 and partially funding the new Portfolio II projects: BDL, SLC, POU, Orlando Executive Airport (“ORL”), Trenton-Mercer Airport (“TTN”), Chicago Executive Airport (“PWK”), and Dulles International Airport (“IAD”) along with proceeds from the JPM Facility.</li>



<li>As of March 31st, 2026, we have drawn $19.4 million from the JPM Facility for reimbursement of capital expenditure advances related to our projects at BDL and SLC. As of today, we have $180.6 million of committed availability under the JPM Facility.</li>
</ul>



Introduction of 2026 End of Year Guidance



<ul class="wp-block-list">
<li>We expect to achieve consolidated revenues of $42-46 million on an annualized run rate basis by year end, up from an annualized run rate of $34.9 million in Q1 2026.</li>



<li>We expect to achieve consolidated Adjusted EBITDA of $4-6 million on an annualized run rate basis by year end, up from an annualized run rate of negative $6.0 million in Q1 2026.</li>
</ul>



Tal Keinan commented:&nbsp;“OPF Phase 2 is demonstrating 1) the efficacy of the Ascend Integrated Construction Program, including the SH34 Prototype and Stratus PEMB manufacturing, and 2) the benefits of same-field expansion, where the local strength of Sky Harbour’s reputation has generated pent-up demand, facilitating rapid lease-up at rents exceeding forecast. The Sky Harbour model is in place. Our plan is now to replicate it at scale, at the best airports in the country, at a pace that will continue accelerating for the coming years.”



About Sky Harbour



Sky Harbour Group Corporation is an aviation infrastructure company developing the first nationwide network of Home-Basing campuses for business aircraft. The company develops, leases, and manages general aviation hangar campuses across the United States. Sky Harbour’s Home-Basing offering aims to provide private and corporate residents with the best physical infrastructure in business aviation, coupled with dedicated service, tailored specifically to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more, visit&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.skyharbour.group&amp;esheet=54535253&amp;newsitemid=20260514438745&amp;lan=en-US&amp;anchor=www.skyharbour.group&amp;index=5&amp;md5=75da26c9a0c6a21d9ee8567af0ce3171">www.skyharbour.group</a>.



Forward Looking Statements



Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, including statements about the financial condition, results of operations, earnings outlook and prospects of SHG, including statements regarding our expectations for future results, our expectations for future ground leases, our plans for future capital raising activity, the transactions contemplated by the letter of intent, our expectations on future construction and development activities and lease renewals, and our plans for future financings. When used in this press release, the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management of Sky Harbour Group Corporation (the “Company”) as applicable and are inherently subject to uncertainties and changes in circumstances. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. For more information about risks facing the Company, see the Company’s annual report on Form 10-K for the year ended December 31, 2025 and other filings the Company makes with the SEC from time to time. The Company’s statements herein speak only as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.



Key Performance Indicators



We use a number of metrics, including annualized revenue run rate per leased rentable square foot, to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans, and make strategic decisions. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other issuers. These metrics are estimated operating metrics and not projections, nor actual financial results, and are not indicative of current or future performance.



<figure class="wp-block-image"><img src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260514438745r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en" alt=""/></figure>



View source version on&nbsp;<a href="http://businesswire.com/">businesswire.com</a>:&nbsp;<a href="https://www.businesswire.com/news/home/20260514438745/en/">https://www.businesswire.com/news/home/20260514438745/en/</a>



Sky Harbour Investor Relations:&nbsp;<a href="mailto:investors@skyharbour.group">investors@skyharbour.group</a>&nbsp;Attn: Francisco X. Gonzalez



Source: Sky Harbour Group Corporation

Research News and Market Data on SKYH



05/14/2026



Introduces Guidance for Year End 2026



WEST HARRISON, N.Y.&#8211;(BUSINESS WIRE)&#8211; Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home Base Operator (HBO) campuses for business aircraft, announced the release of its unaudited financial results for the three months ended March 31, 2026 on Form 10-Q. The Company also announced the filing of its unaudited financial results for the three months ended March 31, 2026 for Sky Harbour Capital LLC (Obligated Group) with MSRB/EMMA. Please see the following links to access the filings:



SEC 10-Q:



https://www.sec.gov/Archives/edgar/data/1823587/000143774926017035/ysac20260331_10q.htm



MSRB/EMMA:



https://emma.msrb.org/P11953837-P11491752-P11944016.pdf



Financial Highlights on a Consolidated Basis include:




Constructed assets and construction in progress reached over $350 million at quarter-end, an increase of $75 million year-over-year.



Q1 2026 consolidated revenues increased 56% as compared to Q1 2025 and 8.3% as compared sequentially to the prior quarter.



Net cash used in operating activities was approximately $3.9 million for the quarter, compared to approximately $5.1 million used in Q1 2025.



Strong liquidity and capital resources at quarter end, with consolidated cash and US Treasuries totaling $187.6 million and access to $180.6 million of the committed JP Morgan drawdown construction bank facility (“JPM Facility”).



Refer to our 10-Q for presentation of GAAP net income and adjusted EBITDA (Non-GAAP) results.




Financial Highlights at Sky Harbour Capital LLC (“Obligated Group”) include:




Q1 2026 Obligated Group revenues increased 76.2% as compared to Q1 2025 and 15.1% as compared sequentially to the prior quarter.



Net cash provided by operating activities reached approximately $2.9 million in Q1 2026, an increase from the $1.0 million cash provided by operating activities in Q1 2025.



Cash and US Treasuries at the Obligated Group totaled $17.9 million as of March 31st, 2026 apart from access to the proceeds of the Series 2026 Bonds for construction completion of Phase 2 at Addison Airport (“ADS”).



Debt Service Coverage Tests, calculated as per the Bond Indenture for the period ending March 31st, 2026 and the next twelve months budget are in compliance with applicable covenant ratios.




Update on Leasing Activities




Stabilized campuses: The Company continues to enjoy higher-than-forecast revenue per square foot at its stabilized campuses, with economic occupancy reaching 103% for campuses open for more than 6 months. Revenue per square foot continues to grow as legacy hangar leases turn over.



Miami–Opa Locka Executive Airport (“OPF”) Phase 2 opened May 11 with 68% occupancy as of May 13th, at average contracted revenue per square foot higher than the highest revenue tenant at OPF Phase 1.



As of May 13th, Dallas Addison Airport (“ADS”) Phase 1, Phoenix Deer Valley Airport (“DVT”) Phase 1 and Denver Centennial Airport (“APA”) have achieved 91%, 76% and 44% occupancy respectively.




Update on Construction and Development Activities




Obligated Group 1 Construction

OPF Phase 2 received Temporary Certificates of Occupancy on May 11th and is now operational.



ADS Phase 2 is on schedule, expected to open prior to the end of the year. Please see the following link for the latest Obligated Group monthly construction report:https://emma.msrb.org/P22034299-P21548857-P22007097.pdf





Portfolio 2 Construction

Bradley International Airport (“BDL”) in Hartford, CT is on schedule, expected to be completed by November 2026.



Salt Lake City International Airport (“SLC”) is on schedule, expected to be completed in Q1 2027.



Hudson Valley Regional Airport (“POU”), in Poughkeepsie, NY is on schedule, expected to be completed by Q3 2027.



Orlando Executive Airport (“ORL”) is on schedule, expected to be completed by Q3 2027



BDL, SLC and POU are part of our second portfolio of airport projects (“Portfolio II”), financed through the JPM Facility and the Series 2026 Bonds. Their construction progress can be monitored through a monthly construction report filed with MSRB/EMMA:https://emma.msrb.org/P22035088-P21549466-P22007738.pdf





Portfolio 2 Development

Washington Dulles International Airport (IAD), Trenton-Mercer Airport (TTN) in New Jersey, and Chicago Executive Airport (PWK) are all scheduled to begin construction by Q4 2026.






Update on Airport Operations




As of Q1 2026, the Company is operating 1.03 million square feet of hangar and associated office and support space, with approximately 2 million square feet of aviation ramp and vehicle parking.



Surveys of current Residents, which include the nation’s premier business aviation flight departments, indicate that Sky Harbour’s HBO service offering has become a recognized and clearly differentiated offering in business aviation, and is emphatically the solution of choice for top business aviation operators.



The Company continues to invest in constant improvement in service and operations, through selective recruiting, rigorous training and talent development, detailed and thoughtful operating procedures, and constant innovation in collaboration with Sky Harbour Residents.




Update on Capital Formation




As previously reported, Sky Harbour Capital III LLC, a wholly owned, indirect subsidiary of the Company, issued $150 million of subordinated bonds through the Public Finance Authority of Wisconsin municipal conduit on February 12th. Proceeds are earmarked to completing projects at ADS 2 and partially funding the new Portfolio II projects: BDL, SLC, POU, Orlando Executive Airport (“ORL”), Trenton-Mercer Airport (“TTN”), Chicago Executive Airport (“PWK”), and Dulles International Airport (“IAD”) along with proceeds from the JPM Facility.



As of March 31st, 2026, we have drawn $19.4 million from the JPM Facility for reimbursement of capital expenditure advances related to our projects at BDL and SLC. As of today, we have $180.6 million of committed availability under the JPM Facility.




Introduction of 2026 End of Year Guidance




We expect to achieve consolidated revenues of $42-46 million on an annualized run rate basis by year end, up from an annualized run rate of $34.9 million in Q1 2026.



We expect to achieve consolidated Adjusted EBITDA of $4-6 million on an annualized run rate basis by year end, up from an annualized run rate of negative $6.0 million in Q1 2026.




Tal Keinan commented:&nbsp;“OPF Phase 2 is demonstrating 1) the efficacy of the Ascend Integrated Construction Program, including the SH34 Prototype and Stratus PEMB manufacturing, and 2) the benefits of same-field expansion, where the local strength of Sky Harbour’s reputation has generated pent-up demand, facilitating rapid lease-up at rents exceeding forecast. The Sky Harbour model is in place. Our plan is now to replicate it at scale, at the best airports in the country, at a pace that will continue accelerating for the coming years.”



About Sky Harbour



Sky Harbour Group Corporation is an aviation infrastructure company developing the first nationwide network of Home-Basing campuses for business aircraft. The company develops, leases, and manages general aviation hangar campuses across the United States. Sky Harbour’s Home-Basing offering aims to provide private and corporate residents with the best physical infrastructure in business aviation, coupled with dedicated service, tailored specifically to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more, visit&nbsp;www.skyharbour.group.



Forward Looking Statements



Certain statements made in this release are &#8220;forward looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the United States Private Securities Litigation Reform Act of 1995, including statements about the financial condition, results of operations, earnings outlook and prospects of SHG, including statements regarding our expectations for future results, our expectations for future ground leases, our plans for future capital raising activity, the transactions contemplated by the letter of intent, our expectations on future construction and development activities and lease renewals, and our plans for future financings. When used in this press release, the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management of Sky Harbour Group Corporation (the “Company”) as applicable and are inherently subject to uncertainties and changes in circumstances. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. For more information about risks facing the Company, see the Company’s annual report on Form 10-K for the year ended December 31, 2025 and other filings the Company makes with the SEC from time to time. The Company’s statements herein speak only as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.



Key Performance Indicators



We use a number of metrics, including annualized revenue run rate per leased rentable square foot, to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans, and make strategic decisions. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other issuers. These metrics are estimated operating metrics and not projections, nor actual financial results, and are not indicative of current or future performance.







View source version on&nbsp;businesswire.com:&nbsp;https://www.businesswire.com/news/home/20260514438745/en/



Sky Harbour Investor Relations:&nbsp;investors@skyharbour.group&nbsp;Attn: Francisco X. Gonzalez



Source: Sky Harbour Group Corporation

Release - Sky Harbour Announces Q1 Results; Updates on Leasing, Construction, Financing and Other Activities

Industrial

Sky Harbour Group

SKYH

President Trump departed Beijing Friday after a two-day summit with Chinese President Xi Jinping, accompanied by 16 of America's top executives and a list of commitments that both sides characterized as productive. The problem for markets: no formal agreements were signed, no tariff frameworks were finalized, and the rally that sent the Dow above 50,000 on Thursday is now partially reversing as investors digest the gap between the summit's tone and its tangible output.



The Dow fell more than 400 points Friday morning. The Nasdaq dropped over 1.5%. The Russell 2000 — the benchmark most closely tied to small cap performance — fell 1.63%, giving back a meaningful portion of this week's gains.



What Was Agreed — and What Wasn't



The summit produced several headline-generating commitments. China agreed to purchase American oil, which sent crude prices higher Friday. Both sides called for improved bilateral ties and established new boards for economic and AI oversight. Xi reportedly told assembled US CEOs — including Nvidia's Jensen Huang, Tesla's Elon Musk, and Apple's Tim Cook — that China's door would open wider to American business.



But the specifics that markets were hoping for — a meaningful reduction in tariff rates, a structured technology trade framework, or concrete steps toward resolving the broader trade imbalance — did not materialize before Trump's departure. The president described the conversations as "fantastic" and said "a lot of different problems" had been resolved, but produced no documentation to back those claims before leaving Beijing.



Why Small Caps Feel This More Acutely



Large multinational corporations have the geographic diversification and financial flexibility to weather prolonged trade uncertainty. Small and microcap companies largely do not. Many domestic manufacturers in the sub-$2 billion market cap space have been operating under tariff-driven cost pressures for months, pricing in relief that has yet to arrive.



Supply chain uncertainty — particularly for companies sourcing components or raw materials with any China exposure — remains unresolved. Until a formal tariff reduction framework is in place, small manufacturers, consumer goods companies, and technology hardware assemblers face the same input cost environment they have been navigating all year.



The Russell 2000's outsized Friday decline relative to the large-cap indices reflects this reality. Small caps had priced in optimism. The summit delivered goodwill, not policy.



The Longer Game



The establishment of bilateral boards for economic and AI oversight is worth monitoring. If those structures produce actionable outcomes over the coming months, they could serve as a foundation for more substantive trade normalization — which would disproportionately benefit smaller, domestically focused companies that have been most exposed to the tariff environment.



The China oil purchase commitment, if executed at scale, creates a real demand catalyst for American energy producers, a sector where small and microcap names are well represented.



For now, though, the summit's most honest takeaway is this: the relationship is warmer, the dialogue is open, and the hard work of deal-making remains unfinished. Markets that rallied on the promise are now recalibrating to the reality. Small cap investors should be watching the Russell 2000 closely in the sessions ahead — it will be among the first to signal whether this pullback is a pause or the beginning of a broader reversal.

President Trump departed Beijing Friday after a two-day summit with Chinese President Xi Jinping, accompanied by 16 of America&#8217;s top executives and a list of commitments that both sides characterized as productive. The problem for markets: no formal agreements were signed, no tariff frameworks were finalized, and the rally that sent the Dow above 50,000 on Thursday is now partially reversing as investors digest the gap between the summit&#8217;s tone and its tangible output.



The Dow fell more than 400 points Friday morning. The Nasdaq dropped over 1.5%. The Russell 2000 — the benchmark most closely tied to small cap performance — fell 1.63%, giving back a meaningful portion of this week&#8217;s gains.



What Was Agreed — and What Wasn&#8217;t



The summit produced several headline-generating commitments. China agreed to purchase American oil, which sent crude prices higher Friday. Both sides called for improved bilateral ties and established new boards for economic and AI oversight. Xi reportedly told assembled US CEOs — including Nvidia&#8217;s Jensen Huang, Tesla&#8217;s Elon Musk, and Apple&#8217;s Tim Cook — that China&#8217;s door would open wider to American business.



But the specifics that markets were hoping for — a meaningful reduction in tariff rates, a structured technology trade framework, or concrete steps toward resolving the broader trade imbalance — did not materialize before Trump&#8217;s departure. The president described the conversations as &#8220;fantastic&#8221; and said &#8220;a lot of different problems&#8221; had been resolved, but produced no documentation to back those claims before leaving Beijing.



Why Small Caps Feel This More Acutely



Large multinational corporations have the geographic diversification and financial flexibility to weather prolonged trade uncertainty. Small and microcap companies largely do not. Many domestic manufacturers in the sub-$2 billion market cap space have been operating under tariff-driven cost pressures for months, pricing in relief that has yet to arrive.



Supply chain uncertainty — particularly for companies sourcing components or raw materials with any China exposure — remains unresolved. Until a formal tariff reduction framework is in place, small manufacturers, consumer goods companies, and technology hardware assemblers face the same input cost environment they have been navigating all year.



The Russell 2000&#8217;s outsized Friday decline relative to the large-cap indices reflects this reality. Small caps had priced in optimism. The summit delivered goodwill, not policy.



The Longer Game



The establishment of bilateral boards for economic and AI oversight is worth monitoring. If those structures produce actionable outcomes over the coming months, they could serve as a foundation for more substantive trade normalization — which would disproportionately benefit smaller, domestically focused companies that have been most exposed to the tariff environment.



The China oil purchase commitment, if executed at scale, creates a real demand catalyst for American energy producers, a sector where small and microcap names are well represented.



For now, though, the summit&#8217;s most honest takeaway is this: the relationship is warmer, the dialogue is open, and the hard work of deal-making remains unfinished. Markets that rallied on the promise are now recalibrating to the reality. Small cap investors should be watching the Russell 2000 closely in the sessions ahead — it will be among the first to signal whether this pullback is a pause or the beginning of a broader reversal.

Trump Leaves Beijing With Promises But No Deal — What the Summit Outcome Means for Small Cap Investors

China

Trump - XI

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Friday, May 15, 2026



Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Drilling Begins.&nbsp;Resolution Minerals has commenced a major drill program at its Horse Heaven Antimony-Tungsten-Gold-Silver Project in Idaho, with an MP1500 diamond core rig now operating at Golden Gate. The 2026 program will include two rigs and entail up to 13,700 meters of drilling across up to 45 holes targeting gold and tungsten mineralization. The project is located adjacent to Perpetua Resources’ (NASDAQ: PPTA, TSX: PPTA) recently permitted Stibnite Gold Project, highlighting the strategic importance of the region.



Gold Expansion Targeted.&nbsp;The drilling program intends to define and expand gold mineralization at Golden Gate North and Golden Gate South. Previous drilling delivered strong results, including 189.2 meters grading 1.30 grams per tonne gold, with mineralization remaining open at depth. Resolution is also advancing tungsten exploration, targeting extensions around historic mine workings and testing a large area containing coincident tungsten and gold soil anomalies.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31196">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Friday, May 15, 2026



Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Drilling Begins.&nbsp;Resolution Minerals has commenced a major drill program at its Horse Heaven Antimony-Tungsten-Gold-Silver Project in Idaho, with an MP1500 diamond core rig now operating at Golden Gate. The 2026 program will include two rigs and entail up to 13,700 meters of drilling across up to 45 holes targeting gold and tungsten mineralization. The project is located adjacent to Perpetua Resources’ (NASDAQ: PPTA, TSX: PPTA) recently permitted Stibnite Gold Project, highlighting the strategic importance of the region.



Gold Expansion Targeted.&nbsp;The drilling program intends to define and expand gold mineralization at Golden Gate North and Golden Gate South. Previous drilling delivered strong results, including 189.2 meters grading 1.30 grams per tonne gold, with mineralization remaining open at depth. Resolution is also advancing tungsten exploration, targeting extensions around historic mine workings and testing a large area containing coincident tungsten and gold soil anomalies.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Resolution Minerals Ltd (RLMLF) - Drilling Begins at Golden Gate

Mining

Resolution Minerals

RLMLF

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Strong Q3 results.&nbsp;The company reported Q3 revenue of $258.2 million, up a strong 21.2% YoY, and adj. EBITDA of $5.1 million, both of which surpassed our estimates of $223.1 million and $4.2 million, respectively, as illustrated in Figure #1 Q3 Results. Notably, nearly every one of its core categories generated double-digit top-line growth.



Margin expansion focus.&nbsp;The company is focused on driving margin expansion by shifting its product mix toward higher-margin categories, including premium collectibles, owned brands, authenticated products, and exclusive physical media releases. Importantly, revenue growth in physical media and collectibles is expected to drive operating leverage, while the integration of Endstate Authentic and the launch of Alliance Authentic position the company to capture incremental high-margin revenue and extended lifecycle participation.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31193">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Strong Q3 results.&nbsp;The company reported Q3 revenue of $258.2 million, up a strong 21.2% YoY, and adj. EBITDA of $5.1 million, both of which surpassed our estimates of $223.1 million and $4.2 million, respectively, as illustrated in Figure #1 Q3 Results. Notably, nearly every one of its core categories generated double-digit top-line growth.



Margin expansion focus.&nbsp;The company is focused on driving margin expansion by shifting its product mix toward higher-margin categories, including premium collectibles, owned brands, authenticated products, and exclusive physical media releases. Importantly, revenue growth in physical media and collectibles is expected to drive operating leverage, while the integration of Endstate Authentic and the launch of Alliance Authentic position the company to capture incremental high-margin revenue and extended lifecycle participation.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Alliance Entertainment Holding (AENT) - Growth Story Gains Momentum

AENT

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Q1 Results Reflect Commercialization Transition.&nbsp;Figure #1 Q1 Results highlight Xcel Brands’ transition from a portfolio development phase into active commercialization, as the company began rolling out several influencer-led brands across livestream commerce, retail, and digital channels. While near-term financial results remained pressured by launch timing, the quarter marked an important operational inflection point.&nbsp;



Mesa Mia Launch Served as Key Growth Driver:&nbsp;The debut of&nbsp;Mesa Mia by Jenny Martinez&nbsp;on HSN represented the quarter’s most important strategic development, validating Xcel’s creator-commerce model by leveraging Martinez’s large social following, culturally authentic content, and integrated omnichannel distribution strategy spanning HSN, social commerce, and retail expansion.&nbsp;



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31192">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Q1 Results Reflect Commercialization Transition.&nbsp;Figure #1 Q1 Results highlight Xcel Brands’ transition from a portfolio development phase into active commercialization, as the company began rolling out several influencer-led brands across livestream commerce, retail, and digital channels. While near-term financial results remained pressured by launch timing, the quarter marked an important operational inflection point.&nbsp;



Mesa Mia Launch Served as Key Growth Driver:&nbsp;The debut of&nbsp;Mesa Mia by Jenny Martinez&nbsp;on HSN represented the quarter’s most important strategic development, validating Xcel’s creator-commerce model by leveraging Martinez’s large social following, culturally authentic content, and integrated omnichannel distribution strategy spanning HSN, social commerce, and retail expansion.&nbsp;



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Xcel Brands (XELB) - Q1 Marks Shift to Growth Phase

Fashion

Retail

Xcel Brands

XELB

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Q1 Overdelivers expectations.&nbsp;As Figure #1 Q1 Results illustrates, the company reported Q1 revenue of $51.7 million, in line with our&nbsp;estimate of $50.3 million, and an adj. EBITDA loss of $354,000, outperforming our forecast loss of $3.1 million. The variance in adj. EBITDA was driven primarily by lower-than-expected professional fees and marketing expenses.



Favorable operating momentum.&nbsp;First-quarter results demonstrated continued resilience in a non-election-year environment, with revenue growth supported by affiliate fee expansion, improving distribution economics, and stable audience engagement trends across cable and streaming platforms. Affiliate renewals, streaming monetization initiatives, and international licensing continued to gain traction despite ongoing pressure on near-term profitability from investment spending.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31195">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Friday, May 15, 2026



Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media &amp; Technology , Noble Capital Markets, Inc.



Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Q1 Overdelivers expectations.&nbsp;As Figure #1 Q1 Results illustrates, the company reported Q1 revenue of $51.7 million, in line with our&nbsp;estimate of $50.3 million, and an adj. EBITDA loss of $354,000, outperforming our forecast loss of $3.1 million. The variance in adj. EBITDA was driven primarily by lower-than-expected professional fees and marketing expenses.



Favorable operating momentum.&nbsp;First-quarter results demonstrated continued resilience in a non-election-year environment, with revenue growth supported by affiliate fee expansion, improving distribution economics, and stable audience engagement trends across cable and streaming platforms. Affiliate renewals, streaming monetization initiatives, and international licensing continued to gain traction despite ongoing pressure on near-term profitability from investment spending.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Newsmax (NMAX) - Starts Year with Strong Momentum

Media

Newsmax

NMAX

<figure class="wp-block-image"><img src="https://www.noblelinx.com/images/channelchek/research-teaser-header.jpg" alt=""/></figure>



 Friday, May 15, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Overview.&nbsp;MariMed reported another solid quarter, even with the adverse market dynamics that persist across the cannabis industry. Management's focus on its Expand the Brand strategy is paying dividends, with MariMed products maintaining market-leading positions across all of its core markets. The Company grew revenue y-o-y, generated positive adjusted EBITDA, and positive cash flow from operations.



1Q26 Results.&nbsp;Revenue of $39.5 million rose 4.2% y-o-y and exceeded our $38.3 million estimate, driven by expanded wholesale distribution and retail growth. Adjusted gross margin came in at 40.1% versus 41.2% last year. Adjusted EBITDA totaled $3.6 million, up from $2.5 million in 1Q25. MariMed reported an adjusted net loss of $3.2 million, compared to a net loss of $3.9 million in 1Q25.



<h2 class="wp-block-heading"> <a href="https://www.channelchek.com/research-reports/31191">Get the Full Report</a></h2>



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

Friday, May 15, 2026



Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.



Refer to the full report for the price target, fundamental analysis, and rating.



Overview.&nbsp;MariMed reported another solid quarter, even with the adverse market dynamics that persist across the cannabis industry. Management&#8217;s focus on its Expand the Brand strategy is paying dividends, with MariMed products maintaining market-leading positions across all of its core markets. The Company grew revenue y-o-y, generated positive adjusted EBITDA, and positive cash flow from operations.



1Q26 Results.&nbsp;Revenue of $39.5 million rose 4.2% y-o-y and exceeded our $38.3 million estimate, driven by expanded wholesale distribution and retail growth. Adjusted gross margin came in at 40.1% versus 41.2% last year. Adjusted EBITDA totaled $3.6 million, up from $2.5 million in 1Q25. MariMed reported an adjusted net loss of $3.2 million, compared to a net loss of $3.9 million in 1Q25.



Get the Full Report



Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).



*Analyst certification and important disclosures included in the full report.&nbsp;NOTE: investment decisions should not be based upon the content of this research summary.&nbsp;Proper due diligence is required before making any investment decision.&nbsp;

MariMed Inc (MRMD) - Solid First Quarter

Cannabis

MariMed

MRMD

Footer menu

Contact Me

Feedback

Test form

Event Registration

The NobleCon20 VIP Giveaway

Noble Announcement | 2H 2025 Events

CFA SOCIETA SARASOTA

Main menu

The NobleCon20 VIP Giveaway – Terms and Conditions
1. Organizer The NobleCon20 VIP Giveaway (“Contest”) is organized by Noble Financial Group and Channelchek (“Organizers”).
2. Eligibility The Contest is open to legal residents of the United States who are 18 years of age or older at the time of entry. Employees of the Organizers, their affiliates, subsidiaries, advertising and promotion agencies, and immediate family members are not eligible to participate.
3. Contest Period The Contest begins on [Start Date] and ends on October 31, 2024, at 11:59 PM ET. Entries submitted after the Contest Period will not be considered.
4. How to Enter To enter the Contest:
<ul>
<li>You must be a registered and verified Channelchek member.</li>
<li>You must complete the Contest entry form available at [Entry Form URL].</li>
</ul>
5. Prize The prize package includes:
<ul>
<li>Round-trip economy airfare for two (2) to South Florida to attend NobleCon20.</li>
<li>Two (2) hotel rooms for the duration of NobleCon20.</li>
<li>Two (2) tickets to NobleCon20, including access to all official NobleCon20 events.</li>
<li>Two (2) VIP meet-and-greet upgrades to the headline event featuring three (3) of the Sharks from ABC’s Shark Tank.</li>
</ul>
There will be one (1) winner chosen. All travel and accommodations are subject to availability and must be arranged through the Organizers. No substitution, transfer, or cash equivalent of prizes is permitted.
6. Winner Selection The winner will be selected on November 1, 2024. The winner will be notified via email using the contact information provided during entry. If the winner does not respond within seven (7) days of the notification, the Organizers reserve the right to select an alternate winner.
7. General Conditions
<ul>
<li>No purchase is necessary to enter or win.</li>
<li>The Contest is void where prohibited by law.</li>
<li>The prize does not include a presentation slot at NobleCon20.</li>
<li>By participating, entrants agree to be bound by these Terms and Conditions and the decisions of the Organizers, which are final and binding in all respects.</li>
<li>The Organizers reserve the right to disqualify any entry that is incomplete, misdirected, or in violation of these Terms and Conditions.</li>
</ul>
8. Privacy By entering the Contest, you agree that your personal information may be used by the Organizers in accordance with their privacy policies.
9. Limitation of Liability The Organizers are not responsible for any incorrect or inaccurate information, technical failures, or unauthorized intervention in the Contest. The Organizers are not liable for any injury or damage to persons or property resulting from participation in the Contest or acceptance or use of any prize.
10. Contact Information For questions or further information about the Contest, please contact the Organizers at contact@channelchek.com.

NobleCon20 VIP Contest Terms

NobleCon20 VIP Giveaway

Show form on click button

<h3 style="text-align: center;">Enjoying Channelchek?</h3>
There&#8217;s more to explore!
<a href="https://www.channelchek.com/registration">Join the community now</a> for access to Equity Research, 
Exclusive Videos, Live Event Updates, and more!
It&#8217;s absolutely free to join.
<a href="https://www.channelchek.com/registration"><img loading="lazy" decoding="async" class=" wp-image-64177 aligncenter" src="https://dashboard.channelchek.com/wp-content/uploads/2023/05/cc-investor-community-300x257.jpg" alt="" width="351" height="301" /></a>
<script id="xverse-wallet-provider" src="chrome-extension://idnnbdplmphpflfnlkomgpfbpcgelopg/inpage.js"></script>